BUSINESS

• Terano Tapped as President of Japan Vaccine
  June 2, 2016

• Chugai Licenses Antibody SA237 to Roche, Japan Filing Slated for 2018
  June 2, 2016

• Ex-Boehringer Japan Pres. Torii to Head Novartis Holdings Japan
  June 2, 2016

• After Tax Hike Delay, Industry Officials Vigilant about Price Slash for Innovative Drugs
  June 2, 2016

• Meiji Plans Japan-Bound Generic Projection in India to Seek Cost Competitiveness
  June 1, 2016

• Meiji Seika Pharma Pins High Hopes on Schizophrenia Drug Sycrest
  June 1, 2016

• Daiichi Sankyo Ceases Development of Patritumab for NSCLC
  June 1, 2016

• Oncolys Concludes Option Agreement with US CRO for HIV Treatment Censavudine
  June 1, 2016

• Takeda Consumer Healthcare Unit Aims for 100 Billion Yen Sales after Spin-Off
  May 31, 2016

• Terumo Debuts Cell-Based Heart Failure Therapy HeartSheet
  May 31, 2016

• Takeda’s Myeloma Drug Hopeful Ninlaro Rebuffed by CHMP
  May 31, 2016

• Takeda Gets CHMP’s Positive Opinion for New Adcetris Indication
  May 31, 2016

• Mylan Japan Labor Union, Management Reach Settlement; All 14 Members to Leave on May 31
  May 30, 2016

• Ethical Drug Sales Up 6.1% in March: Crecon Report
  May 30, 2016

• Application Filing Expected in FY2018 for Cancer Peptide Vaccine Originating from Kurume Univ.
  May 30, 2016

• Kyorin to Exclusively Market MSD’s Desloratadine in Japan
  May 27, 2016

• Astellas Grants Thunderbolt Pharma Rights for BAFF/APRIL Dual Antagonist Program
  May 26, 2016

• Eisai Rolls Out AMPA Receptor Antagonist Fycompa
  May 26, 2016

• AZ Launches Tagrisso for Treatment of NSCLC
  May 26, 2016

• Shionogi’s Naldemedine Delivers Positive Results in Global PIII
  May 25, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 480
• 481
• 482
• 483
• 484
• 485
• 486
• 487
• 488
• …
• Next ›
• 最終 »